Japan told: "deregulate health service"

13 December 2001

Japan should deregulate its health service as soon as possible in orderto create a consumer-friendly society and help economic revival, according to the Council for Regulatory Reform, a government advisory group.

The Council has named six priority areas, including health care, for rapid deregulation, and says the principle is that whatever could be undertaken in the private sector should be left to that sector.

It has also urged increased computerization of claims processing for health care reimbursement, recommended relaxation of the rules on medical advertising and promotion and called for care of the elderly to be opened to the private sector.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight